Bids Are Invited For Requests The Acquisition Of Chemotherapy Drugs, According To Ci Fs/Geriti Nº035/2024.

Pharmacological Group: Antineoplastics, Active Ingredient: Asparaginase, Pharmaceutical Form: Lyophilic Powder, Concentration / Dosage: 10,000, Unit: Ui, Volume: N/A, Presentation: Vial-Ampule, Accessory: N/A, Pharmacological Group: Adjuvant Therapy, Active Ingredient: Finasteride, Pharmaceutical Form: Tablet, Concentration / Dosage: 5, Unit: Mg, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Pharmacological Group: Antianemics, Active Ingredient: Folinic Acid, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration / Dosage: 50 Mg, Presentation: Ampoule Bottle, Active Ingredient: Gemcitabine Hydrochloride, Concentration / Dosage: 1, Unit: G, Volume: 50Ml, Active Ingredient: Ifosfamide, 12/30/2024, Active Ingredient: Mitoxantrone Hydrochloride, Pharmaceutical Form: N/A, Concentration / Dosage: 20, Active Ingredient: Pegaspargase, Form Pharmaceuticals: Injectable Solution, Concentration/Dosage: 750, Unit: U/Ml, Volume: 5 Ml, Supply Form: Unit, Active Ingredient: Rituximab, Concentration / Dosage: 100, Volume: 10 Ml, Concentration / Dosage: 500, Volume: 50 Ml, Active Ingredient: Sulfate Vincristine, Volume: 1 Ml, Presentation: Bottle/Ampule